Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
Breast cancer resistant protein (BCRP) is a molecular determinant of the outcome of photodynamic therapy (PDT) for centrally located early lung cancer
Lung Cancer, 07/02/09
Usuda J et al. - Photofrin may be a substrate of BCRP and be pumped out from the cells, therefore, BCRP may be a molecular determinant of the outcome of Photofrin-PDT.
Today in Photodermatology...keeping you current
Receive free subspecialty "5-minute updates" via email
A practical approach to using methotrexate
Dermatology in Practice, 10/09/09
Topical treatment of melasma
Indian Journal of Dermatology, 11/20/09
Skin cancer: preventive photodynamic therapy in patients with face and scalp cancerization. A randomized placebo-controlled study
British Journal of Dermatology, 11/02/09
Sponsor
Article Search
Sponsor


See Latest Articles


